What does the evidence say about Probiotics Sleep Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Probiotics Sleep Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - It is estimated that fibromyalgia can result in up to approximately 36 000$ of annual direct costs per patient in the US, imposing a considerable burden on the health care systems. [Nakhostin-Ansari Amin (2026); evidence level 1] - The presence of these comorbid medical conditions can make the diagnosis of fibromyalgia challenging, which could lead to mismanagement, overtreatment, and increased drug side effects. [Nakhostin-Ansari Amin (2026); evidence level 1] - Therefore, proper diagnosis of fibromyalgia and its associated comorbidities is crucial for effective management of the conditions. [Nakhostin-Ansari Amin (2026); evidence level 1] - 1 2 [,] 3 [] 4 [] 5 6 [,] 7 8 [,] 7 8 [,] 5 [] Fibromyalgia is a syndrome characterized by chronic widespread musculoskeletal pain, often accompanied by a range of other symptoms, including sleep disturbances, excessive fatigue, and psychological issues such as depression. [Nakhostin-Ansari Amin (2026); evidence level 1] - 6 7 8 9 Insufficient sleep and poor sleep quality are associated with daytime sleepiness and reduced performance and are also linked to increased metabolic and cardiovascular risk and adverse mental health outcomes []. [Kim Hayoung (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.